Company performance
Add to research
Current Price
as of Apr 22, 2025$6.03
P/E Ratio
N/A
Market Cap
$157M
Description
Add to research
CVRx, Inc. engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It operates through the following geographical segments: United States, Germany, and Other Countries. The company was founded by Robert S. Kieval and Tyler P. Lipschultz in August 2001 and is headquartered in Minneapolis, MN.
Metrics
Add to research
Overview
- HQMinneapolis, MN
- SectorHealth Technology
- IndustryMedical Specialties
- TickerCVRX
- Price$6.03-0.50%
Trading Information
- Market cap$157.00M
- Float60.25%
- Average Daily Volume (1m)497,906
- Average Daily Volume (3m)324,374
- EPS-$2.65
Company
- Revenue$51.29M
- Rev growth (1yr)30.53%
- Net income-$59.97M
- Gross margin82.55%
- EBITDA margin-114.78%
- EBITDA-$58.87M
- EV$230.79M
- EV/Revenue4.50
- P/EN/A
- P/S2.66
- P/B2.15
- Debt/Equity70.98
Documents
Add to research
SEC Filings
Factset Street Account
Earnings Calls
Factset